Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Mehr anzeigen
Median overall survival (OS) among patients with HR+, HER2- advanced breast cancer who were treatment-naïve in the advanced setting was 77.3 months Median OS among patients previously treated...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.55 | 4.70085470085 | 11.7 | 13.145 | 11.49 | 203640 | 12.49308687 | CS |
| 4 | -0.12 | -0.970088924818 | 12.37 | 13.145 | 10.3537 | 239821 | 11.58212229 | CS |
| 12 | -1.82 | -12.9353233831 | 14.07 | 14.19 | 10.3537 | 280677 | 12.43047388 | CS |
| 26 | -4.35 | -26.2048192771 | 16.6 | 18 | 10.3537 | 284721 | 14.25558994 | CS |
| 52 | -3.45 | -21.974522293 | 15.7 | 22.188 | 10.3537 | 284834 | 15.69259006 | CS |
| 156 | 1.4 | 12.9032258065 | 10.85 | 22.188 | 4.81 | 143862 | 13.99395865 | CS |
| 260 | 1.25 | 11.3636363636 | 11 | 33.01 | 4.03 | 119005 | 15.95331094 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
